当前位置: X-MOL 学术Aliment. Pharm. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-09-02 , DOI: 10.1111/apt.16593
Mette Julsgaard 1, 2 , Daniel C Baumgart 3 , Simon M D Baunwall 1 , Mette M Hansen 1 , Anne Grosen 1 , Bo M Bibby 1 , Niels Uldbjerg 1 , Jens Kjeldsen 4 , Heidi G Sørensen 5 , Lone Larsen 6 , Signe Wildt 7 , Petra Weimers 8 , Kent V Haderslev 9 , Ida Vind 10 , Lise Svenningsen 2 , Jørn Brynskov 11 , Søren Lyhne 12 , Thea Vestergaard 1 , Christian L Hvas 1 , Jens Kelsen 1 ,
Affiliation  

Little is known about the consequences of intrauterine exposure to, and the post-natal clearance of, vedolizumab.

中文翻译:

新生儿维多珠单抗清除率、感染易感性和发育里程碑:一项前瞻性多中心人群队列研究

关于宫内暴露于维多珠单抗的后果和产后清除率知之甚少。
更新日期:2021-10-27
down
wechat
bug